PMID- 22864134 OWN - NLM STAT- MEDLINE DCOM- 20130110 LR - 20190606 IS - 1349-7235 (Electronic) IS - 0918-2918 (Linking) VI - 51 IP - 15 DP - 2012 TI - Sitagliptin (DPP-4 inhibitor)-induced rheumatoid arthritis in type 2 diabetes mellitus: a case report. PG - 2041-4 AB - A dipeptidyl peptidase (DPP)-4 inhibitor, commonly used to treat patients with type 2 diabetes, has caused concern because of immune system side effects. We report a 48-year-old woman with type 2 diabetes who was diagnosed with rheumatoid arthritis (RA) after continued polyarthritis and an increase in rheumatoid factor up to 86 IU/mL after three months of treatment with sitagliptin, a DPP-4 inhibitor. The shared epitope (SE)-containing human leukocyte antigen (HLA)-DRB1 alleles, which are important predisposing factors for RA, were positive. RA might have been triggered by sitagliptin due to a predisposing condition. FAU - Yokota, Kazuki AU - Yokota K AD - Kobe University Graduate School of Medicine, Japan. yoyochibiakiko@yahoo.co.jp FAU - Igaki, Naoya AU - Igaki N LA - eng PT - Case Reports PT - Journal Article DEP - 20120801 PL - Japan TA - Intern Med JT - Internal medicine (Tokyo, Japan) JID - 9204241 RN - 0 (Dipeptidyl-Peptidase IV Inhibitors) RN - 0 (HLA-DRB1 Chains) RN - 0 (Pyrazines) RN - 0 (Triazoles) RN - 9009-79-4 (Rheumatoid Factor) RN - TS63EW8X6F (Sitagliptin Phosphate) SB - IM MH - Alleles MH - Arthritis, Rheumatoid/*etiology/genetics/immunology MH - Diabetes Mellitus, Type 2/complications/*drug therapy MH - Dipeptidyl-Peptidase IV Inhibitors/adverse effects MH - Female MH - Genetic Predisposition to Disease MH - HLA-DRB1 Chains/genetics/immunology MH - Humans MH - Middle Aged MH - Pyrazines/*adverse effects MH - Rheumatoid Factor/blood MH - Sitagliptin Phosphate MH - Triazoles/*adverse effects EDAT- 2012/08/07 06:00 MHDA- 2013/01/11 06:00 CRDT- 2012/08/07 06:00 PHST- 2012/08/07 06:00 [entrez] PHST- 2012/08/07 06:00 [pubmed] PHST- 2013/01/11 06:00 [medline] AID - DN/JST.JSTAGE/internalmedicine/51.7592 [pii] AID - 10.2169/internalmedicine.51.7592 [doi] PST - ppublish SO - Intern Med. 2012;51(15):2041-4. doi: 10.2169/internalmedicine.51.7592. Epub 2012 Aug 1.